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Abstract
The voltage−gated K+ (Kv) channel subunits Kv2.1 and Kv2.2 are expressed in almost every
tissue. The diversity of Kv2 current is increased by interacting with the electrically silent Kv
(KvS) subunits Kv5−Kv6 and Kv8−Kv9, into functional heterotetrameric Kv2/KvS channels.
These Kv2/KvS channels possess unique biophysical properties and display a more tissue-
specific expression pattern, making themmore desirable pharmacological and therapeutic
targets. However, little is known about the pharmacological properties of these heterotetra-
meric complexes. We demonstrate that Kv5.1, Kv8.1 and Kv9.3 currents were inhibited differ-
ently by the channel blocker 4−aminopyridine (4−AP) compared to Kv2.1 homotetramers. In
contrast, Kv6.4 currents were potentiated by 4−APwhile displaying moderately increased
affinities for the channel pore blockers quinidine and flecainide. We found that the 4−AP
induced potentiation of Kv6.4 currents was caused bymodulation of the Kv6.4−mediated
closed−state inactivation: suppression by 4−AP of the Kv2.1/Kv6.4 closed−state inactivation
recovered a population of Kv2.1/Kv6.4 channels that was inactivated at resting conditions, i.e.
at a holding potential of −80mV. This modulation also resulted in a slower initiation and faster
recovery from closed−state inactivation. Using chimeric substitutions between Kv6.4 and
Kv9.3 subunits, we demonstrated that the lower half of the S6 domain (S6c) plays a crucial
role in the 4−AP induced potentiation. These results demonstrate that KvS subunits modify
the pharmacological response of Kv2 subunits when assembled in heterotetramers and illus-
trate the potential of KvS subunits to provide unique pharmacological properties to the hetero-
tetramers, as is the case for 4−AP on Kv2.1/Kv6.4 channels.
Introduction
Voltage−gated K+ (Kv) channels are K+ selective membrane proteins that open, close and/or inac-
tivate in response to changes in the membrane potential [1]. They exist as tetramers of α−subunits
each consisting of six transmembrane segments (S1−S6) [2]. The four S5−S6 segments generate
the central ion conducting pore while the S1−S4 segments form the voltage−sensing domains
(VSDs). The channel pore can be sealed off by the channel gate at the level of the S6 bundle
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crossing (BC) [3,4]. Opening and closure of this BC gate is controlled by the VSDs that detect
changes in the membrane potential. The highly conserved PXPmotif (Fig 1) near the intracellular
end of S6 (S6c) functions as a hinge that allows the necessary swiveling and bending motions [5–
7]. In addition to forming the BC gate, the S6c region (including the PXPmotif) has also been
implicated in determining the channel’s affinity for pore blockers [8–12].
Based on sequence homology, the Kv superfamily has been divided into eight closely
Shaker−related subfamilies: Kv1−Kv6 and Kv8−Kv9 [13]. Unlike the Kv1−Kv4 subunits,
members of the Kv5, Kv6, Kv8 and Kv9 subfamilies–designated silent Kv (KvS) subunits–do
not produce functional homotetramers on their own, despite possessing most of the hall-
marks of a typical Kv channel subunit. However, KvS subunits lack the 2nd proline residue of
the highly conserved PXP motif. KvS subunits assemble with Kv2 subunits into functional
Kv2/KvS heterotetramers that possess unique biophysical properties; KvS subunits shift the
voltage dependence of inactivation and/or activation, affect the current density and modulate
the kinetics of both activation and deactivation compared to Kv2 homotetramers [14]. The
different Kv2/KvS channels also display a more tissue−specific expression compared to
Kv2.1 homotetramers which are expressed in almost every tissue, e.g. Kv6.4 is abundantly
expressed in brain tissue and weakly expressed in liver, small intestine and colon [15]. There-
fore, heterotetramerization of KvS with Kv2 subunits is thought to increase the functional
diversity and most likely serves tissue−specific functions for these Kv2/KvS channel com-
plexes. Indeed, heterotetrameric Kv2.1/Kv9.3 channels are involved in hypoxic pulmonary
Fig 1. Sequence alignment of the S6 segment of various Kv and KvS subunits. The PXPmotif (red) is conserved between the Shaker and Kv1−Kv4
subunits. The Kv7.1 subunit displays a glycine (could confer flexibility) while the Kv5, Kv6, Kv8 and Kv9 (or KvS) subunits contain residues that would
promote an alpha−helical configuration. The S6c segment used to make the chimeric substitution between Kv6.4 and Kv9.3 is highlighted in bold.
doi:10.1371/journal.pone.0141349.g001
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artery vasoconstriction [16,17], mutations in Kv8.2 have been associated with an inherited
retinal dystrophy [18] and epilepsy susceptibility [19] and recently the involvement of Kv6.4
in a fast motor neuron biophysical signature has been demonstrated [20].
Because the S6c sequence of KvS subunits differs from that of Kv2 subunits and since certain
Kv2/KvS combinations appear to display a more tissue−specific expression than the more
ubiquitously expressed Kv2 subunits, these Kv2/KvS heterotetramers have a therapeutic poten-
tial as more specific pharmacological targets. In this study, we demonstrate that Kv6.4 subunits
confer a distinct pharmacological profile to the Kv2.1/Kv6.4 heterotetramers for the common
channel inhibitor 4−aminopyridine (4−AP) in which the Kv6.4 S6c sequence plays an impor-
tant role. 4−AP is known to inhibit Kv2.1 channels, but surprisingly it potentiated the Kv2.1/
Kv6.4 current. This 4−AP response was unique for the Kv2.1/Kv6.4 heterotetramers and not




Human Kv2.1, Kv5.1, Kv6.4, Kv8.1 and mouse Kv9.3 were subcloned in the eGFP−N1 vector
(Clontech, Palo Alto, CA, USA) as previously described [15]. The chimeric Kv6.4 and Kv9.3
constructs Kv6.4_S6c_Kv9.3 and Kv9.3_S6c_Kv6.4 in which the C−terminal end of the Kv6.4
and Kv9.3 S6 segments (S6c) were exchanged for that of Kv9.3 and Kv6.4, respectively (Fig 1),
were constructed using a loop-in PCR strategy using mutant primers and the Quickchange Site
−Directed Mutagenesis kit (Stratagene, La Jolla, CA, USA) as previously reported [21,22]. To
confirm the presence of the desired S6c sequence exchange and the absence of unwanted muta-
tions, the amplified cDNA was sequenced.
Transient transfection and cell culture
Mouse fibroblast Ltk− cells (American Type Culture Collection CLL. 1.3) were chosen for the
electrophysiological experiments because of low levels of endogenous current [23,24]. Ltk- cells
were cultured in Dulbecco’s modified Eagle’s medium supplemented with 10% horse serum
(purchased from Gibco1, Life Technologies, Gent, Belgium) and 1% penicillin/streptomycin
at 37°C and under 5% CO2. Ltk
− cells were transiently transfected with 0.05 μg– 5 μg cDNA of
wild type (WT) or mutant channel subunits along with 0.5 μg eGFP as transfection marker
using the polyethylenimine reagent (Sigma−Aldrich, St. Louis, MO, USA) according to the
manufacturer’s instruction. To ensure that only a population of heterotetrameric Kv2.1/KvS
channels was formed, the KvS and Kv2.1 subunits were co−transfected in a 10:1 cDNA ratio.
Twenty−four hours post transfection the Ltk− cells were trypsinized and used for the
electrophysiological experiments.
Electrophysiology
Current recordings were obtained in the whole cell configuration at room temperature (20
−23°C) with an Axopatch−200B amplifier (Axon Instruments, Union City, CA, USA). The cur-
rent recordings were low−pass filtered through a Bessel filter and sampled at 1 − 10 kHz with a
Digidata 1200A data acquisition system (Axon Instruments). Data storage and command volt-
ages were controlled with the pClamp10 software (Axon Instruments). Pipettes were pulled
using a P−2000 puller (Sutter Instruments, Novato, CA, USA) from borosilicate glass capillar-
ies (World Precision Instruments, Sarasota, FL, USA) and afterwards heat polished to obtain
patch pipettes with a resistance between 1 MO− 2.5 MO. The patch pipettes were filled with an
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intracellular solution (ICS) containing 110 mM KCl, 5 mM K2ATP, 5 mM K4BAPTA, 2 mM
MgCl2, 10 mMHEPES and adjusted to pH 7.2 with KOH. The Ltk
− cells were continuously
perfused with an extracellular solution (ECS) containing 145 mMNaCl, 4 mM KCl, 1 mM
MgCl2, 1.8 mM CaCl2, 10 mMHEPES, 10 mM glucose and adjusted to pH 7.35 with NaOH.
Junction potentials between the ICS and ECS were zeroed with the filled pipette in the bath
solution. 4−aminopyridine (4−AP) (Sigma−Aldrich), flecainide (S.A. Meda Pharma N.V.,
Brussels, Belgium) and quinidine (Eli Lilly & co, Indianapolis, IN, USA) were diluted in ECS
solution to obtain a stock solution of 180 mM, 2 mM and 1 mM, respectively. Stock solutions
were balanced to a pH of 7.35. The desired working concentrations of 4−AP, flecainide and
quinidine were made by diluting these stock solutions in ECS solution and were applied by
using a fast perfusion system (ALA Scientific Instruments, Farmingdale, NY, USA).
Data analysis and statistics
Voltage protocols are represented in the figures and were adjusted to the biophysical properties
of the different Kv channels. The voltage dependence of activation and inactivation was fitted
with a single Boltzmann function according to y = 1 / (1 + exp (−(V–V1/2) / k)), withV represent-
ing the voltage applied, V1/2 the voltage at which 50% of the channels are activated or inactivated,
and k the slope factor. Time constants of activation (from + 80 to −10 mV) and deactivation
(−20 to −70 mV) were obtained by fitting the raw current traces of either the activation or deacti-
vation (not shown) protocol with a single or double exponential function. Dose−response curves
were obtained by plotting y, the fraction of current remaining at +30mV, as a function of drug
concentration, [D], and fitted with the Hill equation: 1 –y = 1 / (1 + (IC50 / [D])
n
H), where IC50 is
the concentration that generates 50% inhibition and nH the Hill coefficient. Results are expressed
as mean ± S.E.M. Statistical difference was determined with standard t−test if applicable or the
Mann−Whitney Rank Sum test. P< 0.05 was considered significant.
Nomenclature
We reported in 2002 the cloning and properties of three KvS subunits designated Kv6.3,
Kv10.1 and Kv11.1, based on the degree of sequence homology in the S1-S6 region [15]. The
Kv subunit nomenclature was revised by IUPHAR in 2005 [13]. Kv10.1 became Kv6.3, Kv6.3
was renamed to Kv6.4 and Kv11.1 to Kv8.2. Thus, the Kv6.4 mentioned in this paper is the KvS
subunit that displayed the largest hyperpolarizing shift in the voltage-dependence of inactiva-
tion in the original report [15].
Results
4−AP potentiates Kv2.1/Kv6.4 currents while inhibiting other Kv2/KvS
combinations
A common feature of all the KvS subunits is that they lack the 2nd proline residue of the PXP
motif within the bottom end of the S6 segment (S6c) (Fig 1), a channel region that has been
shown to be involved in the interaction with pore blockers [8–10]. Substituting the 2nd proline
of the PXP motif by an alanine or glycine drastically reduced the 4−AP affinity of the Shaker
Kv channel [25]. This raised the question whether the KvS subunits also affect the pharmaco-
logical profile of Kv2 containing heteromers, in addition to altering the biophysical properties.
Since the effect of 4−AP on Kv2/KvS heteromeric channels has not been investigated exten-
sively, we screened heterotetramers of Kv2.1 and either Kv5.1, Kv6.4, Kv8.1 or Kv9.3 for their
sensitivity to 4−AP (Fig 2). These KvS subunits were chosen as representative members for
each of the four KvS subfamilies. Application of 18 mM 4−AP, which is the reported IC50 value
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for Kv2.1 inhibition [26,27], blocked 10 ± 2%, 56 ± 2% and 12 ± 1% of Kv5.1, Kv8.1 and Kv9.3
containing currents, respectively (n = 7) (Fig 2A and 2B). Full dose−response relationships for
the different heterotetrameric Kv2.1/KvS and for homotetrameric Kv2.1 channels were deter-
mined and compared to obtain a relative measurement of the 4−AP sensitivity (Fig 2C). No
proper IC50 value and Hill coefficient (nH) could be determined for the Kv2.1/Kv5.1 and
Kv2.1/Kv9.3 channel due to their weak sensitivity for 4-AP inhibition (Fig 2C). Kv2.1/Kv8.1
channels displayed sufficient sensitivity and were inhibited with an IC50 of 24.1 ± 2.0 mM and
nH = 1.4 ± 0.2 (n = 5). Homotetrameric Kv2.1 channels displayed an IC50 of 4.5 ± 1.8 mM
(n = 6) for inhibition by 4−AP, and Hill coefficient nH of 1.0 ± 0.1 (n = 6), which is a higher
affinity compared to the value of 18mM reported previously [27]. However, this difference
most likely reflects the difference in experimental conditions namely the used heterologous
expression system. Our IC50 value corresponds well with the reported sensitivity in HEK cells
and cultivated neurons/myocytes (0.5mM to 5mM) [28,29] but is lower compared to similar
experiments performed in oocytes (18mM) [27]. The dose−response relationships of Kv5.1,
Kv8.1 and Kv9.3 currents were all right−shifted towards a higher concentration range in com-
parison to Kv2.1 currents. Thus, Kv5.1, Kv8.1 and Kv9.3 heterotetramers display an altered
sensitivity for 4−AP.
Interestingly, application of 4−AP increased the Kv6.4 current by 16 ± 1% (n = 9). To
exclude that this effect was due to a potential change in intracellular pH caused by the high
4−AP concentration, we increased the buffering capacity of the “intracellular” pipette solution
from 10 mM to 20 mMHEPES; even with this solution we observed an increase in Kv2.1/
Kv6.4 currents after 4−AP application. This potentiating effect of 4-AP was not conserved
within the Kv6 subfamily because heterotetrameric Kv2.1/Kv6.3 channels (before the IUPHAR
classification also known as Kv10.1) were inhibited by 4-AP (S1A Fig), although with a reduced
sensitivity compared to homotetrameric Kv2.1 channels (S1 Fig)[13,15].
To examine whether this effect was unique to 4−AP, we tested the effect of two other chan-
nel blockers − quinidine and flecainide − on Kv2.1/Kv6.4 channels (S2 Fig). Unlike 4−AP, both
quinidine and flecainide blocked Kv2.1/Kv6.4 currents; the IC50 values of quinidine and flecai-
nide for heterotetrameric Kv2.1/Kv6.4 channels were 3.0 ± 0.1 μM (n = 7, S2B Fig) and
2.0 ± 0.1 μM (n = 5, S2D Fig), respectively, which is twice as sensitive compared to Kv2.1
homotetramers (IC50 = 7.2 ± 0.8 μM, n = 7 and 7.4 ± 0.8 μM, n = 4 respectively). While not
extensive, these changes in IC50 values were statistically significant (p = 0.008 and p< 0.001
for flecainide and quinidine, respectively).
4−AP affects closed−state inactivation in Kv6.4 containing channels
4−AP not only decreased the ionic current of homotetrameric Kv2.1 channels, but also slowed
the activation kinetics. This is illustrated in S3A and S3C Fig [30]. Furthermore, we observed
that 18 mM 4−AP shifted the voltage dependence of channel activation by approximately 17
mV towards more positive potentials (S3B Fig) and markedly slowed the apparent rate of acti-
vation (S3C Fig). In contrast, Fig 3B and Table 1 show that 4−AP did not significantly alter the
voltage dependence of activation of heterotetrameric Kv2.1/Kv6.4 channels (p = 0.090). 4−AP
did alter the activation time course of Kv2.1/Kv6.4 channels (Fig 3A) but in a different manner
compared to Kv2.1 homotetramers (S3C Fig). 4−AP eliminated the slow component of the
Kv2.1/Kv6.4 activation time course and although it slowed the fast component 2−fold (Fig 3C),
the final result was a relatively faster activation, as observed in Fig 3A.
While not significantly altering the voltage dependence of activation, 4−AP shifted the volt-
age dependence of inactivation of Kv2.1/Kv6.4 channels slightly towards more depolarized
potentials (p = 0.031, Fig 3D and Table 1). To exclude that this was due to a possible
Silent Kv Subunits Diversify Kv2.1 Pharmacology
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depolarizing drift in our recordings, the V1/2 of inactivation was performed over the course of
25 min. (S4A Fig). The V1/2 of inactivation displayed a small, non significant drift towards
hyperpolarized potentials when comparing the initial recording (t = 5 min.) with the final
Fig 2. KvS subunits have a distinct pharmacological profile for the channel blocker 4−AP. (A) Effect of
4−AP on Kv2.1/KvS heterotetramers. Application of 4−AP (colored traces) yielded different amounts of block
for Kv5.1, Kv8.1 and Kv9.3 containing Kv2.1/KvS complexes. Remarkably, 4−AP caused a current increase
for Kv2.1/Kv6.4 heterotetramers. Control traces are shown in black and recorded at +30mV. Washout traces
are shown in dark grey. (B) Current−voltage relationships for the different Kv2.1/KvS heterotetramers
obtained by plotting the normalized current amplitude (to the current amplitude under control conditions) in
function of the pulse potential. (C) Concentration−effect relationships of homotetrameric Kv2.1 (black circles)
and heterotetrameric Kv2.1/Kv5.1 (blue squares), Kv2.1/Kv8.1 (green downward triangles) and Kv2.1/Kv9.3
(orange upward triangles) channels. All Kv2.1/KvS heterotetramers possess a reduced 4−AP affinity
observed as right−shifted concentration−effect curves. Lines represent the fit of the concentration−effect
curves with the Hill equation as mentioned in the material and methods section.
doi:10.1371/journal.pone.0141349.g002
Fig 3. Effect of 4−AP on the gating properties of Kv2.1/Kv6.4 heterotetramers. (A) Representative current recordings of Kv2.1/Kv6.4 before (left) and
after application of 4−AP (right). 4−AP potentiated Kv2.1/Kv6.4 currents and accelerated the activation kinetics. (B) Voltage dependence of activation with
(red) and without 4−AP (black). The voltage dependence of activation was derived from plotting the normalized tail currents in panel A in function of the
prepulse potential. (C) Activation and deactivation kinetics of the Kv2.1/Kv6.4 heterotetramers. Time constants were obtained with a double exponential
function yielding a fast (circles) and slow (triangles) component under control conditions. 4−AP (red) abolished the slow component in the activation but left
the fast component largely unaffected. (D) The voltage dependence of inactivation before (black) and after application of 4−AP (red). The voltage
−dependence of inactivation was obtained by plotting the normalized peak amplitude at +60mV after a 5s prepulse in function of the prepulse potential. 4−AP
(red symbols) did not significantly alter the voltage dependence of activation but significantly reduced the degree of U−shaped inactivation. For comparison,
homomeric Kv2.1 (dotted line) before 4−AP application is included. (E) Concentration−dependence of the 4−AP induced potentiation relative to control. The
solid line represents a fit with the Hill equation with EC50 of 3.2 ± 0.2 mM (n = 4).
doi:10.1371/journal.pone.0141349.g003
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recording (t = 25 min.) (p = 0.343). However, 4-AP (recorded after such time course analysis)
still significantly shifted the inactivation process towards depolarizing potentials (p = 0.019)
(S4B and S4C Fig).
Kv2.1/Kv6.4 channels inactivate before the BC gate opens as reflected by the 60 mV differ-
ence between the midpoint of the voltage dependence of inactivation and activation. In addi-
tion, Kv2.1/Kv6.4 channels possess, as illustrated in panel D of Fig 3 (black circles), a strong
U−shaped inactivation profile, indicative of preferential inactivation from closed and inter-
mediate open states while displaying less efficient inactivation from the open state, a process
also known as closed-state inactivation [31–34]. Fig 3D reveals that 4−AP not only reduced
the amount of Kv2.1/Kv6.4 channel inactivation during the 5 second prepulse but also the
degree of U−type inactivation. The reduction in channel inactivation was most pronounced
at potentials below the threshold for BC gate opening, i.e. more negative than −40 mV.
Under control conditions 12 ± 2, 23 ± 3, 46 ± 5 and 73 ± 3% (n = 8) of Kv2.1/Kv6.4 channels
are inactivated at −80, −70, −60 and −50 mV, respectively; 4−AP significantly decreased the
amount of inactivation at these potentials to roughly 1 (p = 0.033), 12 ± 3 (p = 0.044), 31 ± 6
(p = 0.041) and 55 ± 7% (p = 0.036), respectively (n = 7) (Fig 3D). This suggested that 4−AP
prevented (or reduced) the transition from a closed state to a closed−inactivated state in
Kv2.1/Kv6.4 channels. The concentration−dependence of the 4−AP induced current increase
saturated at concentrations above 10 mM, EC50 = 2.9 ± 0.1 mM (n = 5), but for consistency,
all of the following experiments were performed with the 18 mM 4−AP screening concentra-
tion (Fig 3E).
Effect of 4−AP on the kinetics of closed−state inactivation
4−AP could interfere with the closed to closed−inactivated state transition in Kv2.1/Kv6.4
channels by altering the induction of and/or recovery from closed−state inactivation. To
investigate whether 4−AP affects the rate of development of closed−state inactivation, we
used a protocol as illustrated in Fig 4A; the initial current amplitude was recorded at a test
pulse to +60 mV (P1) followed by a 5s recovering pulse to −100 mV to eliminate any
Table 1. Overview of the biophysical properties for Kv2.1, Kv2.1/Kv6.4, Kv2.1/Kv6.4_S6c_Kv9.3 and Kv2.1/Kv9.3_S6c_Kv6.4 channels.
Control 18mM 4-AP
V1/2 (mV) k n V1/2 (mV) k n
Activation Kv2.1 −2.0 ± 0.9 9.7 ± 0.5 6 15.4 ± 1.3 12.8 ± 0.8 6
Kv6.3 5.6 ± 2.3 10.1 ± 0.6 7 13.8 ± 2.0 10.9 ± 1.4 5
Kv6.4 1.5 ± 1.4 20.0 ± 1.0 9 −0.3 ± 1.9 21.3 ± 2.1 9
Kv6.4_S6c_Kv9.3 −2.6 ± 1.0 13.2 ± 0.3 8 −0.5 ± 1.2 15.5 ± 0.7 8
Kv9.3 −5.7 ± 1.7 10.3 ± 0.2 5 −7.0 ± 0.5 8.9 ± 0.6 5
Kv9.3_S6c_Kv6.4 6.7 ± 1.2 11.0 ± 0.9 6 4.8 ± 1.3 10.2 ± 0.3 6
Inactivation Kv2.1 −19.4 ± 2.3 6.3 ± 0.5 6 −11.4 ± 1.0 5.6 ± 0.6 6
Kv6.3 -20.0 ± 3.8 6.9 ± 0.4 5 -4.8 ± 1.5 8.0 ± 0.6 5
Kv6.4 −59.0 ± 1.2 8.4 ± 0.4 7 −52.0 ± 2.6 7.7 ± 0.1 7
Kv6.4_S6c_Kv9.3 −58.5 ± 1.4 7.7 ± 0.2 5 −56.8 ± 1.2 7.9 ± 0.8 5
Kv9.3 −48.7 ± 1.4 7.0 ± 0.5 5 −45.4 ± 1.2 7.8 ± 0.7 5
Kv9.3_S6c_Kv6.4 −31.3 ± 0.7 7.3 ± 0.3 5 −28.7 ± 2.0 8.4 ± 0.8 5
V1/2, midpoint of activation and inactivation; k, slope factor; n, number of cells. Values in bold are significantly different (p < 0.05) compared to control
values
doi:10.1371/journal.pone.0141349.t001
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inactivation that had developed, a pulse of variable duration to −60 mV to develop closed
−state inactivation and a second test pulse to +60 mV (P2) to obtain the current amplitude
after the initiation of closed−state inactivation. The fraction P2/P1 represents the degree of
inactivation and was plotted against the time spent at −60 mV (Fig 4C, normalized plot). The
holding potential was kept at −100 mV to avoid development of closed−state inactivation
between the different current traces. Under control conditions (upper panel Fig 4A, black cir-
cles Fig 4C) approximately 70% of the Kv2.1/Kv6.4 channels were inactivated after 50s at
−60 mV and closed−state inactivation developed with a time constant of 5.4 ± 0.2 s (n = 6).
In the presence of 4−AP (lower panel Fig 4A, red circles Fig 4C), the total amount of inactiva-
tion was reduced to approximately 40% and the time constant was increased to 9.3 ± 0.9 s
(n = 6, p = 0.032). To investigate the rate of recovery from closed−state inactivation, a similar
protocol was used (Fig 4B); the initial +60 mV (P1) and recovery −100 mV pulse remained
the same but were now followed by a 10 s pulse to −60 mV to induce closed−state inactiva-
tion, followed by a pulse of variable duration to −100 mV to allow the channels to recover
from closed−state inactivation and a second test pulse to +60 mV (P2) to obtain the current
amplitude after the recovery from closed−state inactivation. The P2/P1 ratio now represents
the fraction of Kv2.1/Kv6.4 channels that had recovered from a closed−inactivated state (Fig
4D). In the presence of 4−AP, Kv2.1/Kv6.4 channels recovered faster from closed−state inac-
tivation (τ = 0.5 ± 0.1 s, n = 6) compared to the Kv2.1/Kv6.4 recovery under control condi-
tions (τ = 1.2 ± 0.2s, n = 6, p = 0.009). These results suggest that 4−AP prevented (or
reduced) the transition from the closed to closed−inactivated state of Kv2.1/Kv6.4 channels
by slowing the induction of closed−state inactivation and increasing the rate of recovery
from closed−state inactivation.
To confirm that 4−AP interferes with the transition from the closed state to the closed−inacti-
vated state in Kv2.1/Kv6.4 channels, a twin−pulse protocol was used: two depolarizing pulses to
+60 mV were separated by a 10 s interval at −100 mV allowing the Kv2.1/Kv6.4 channels to
recover from closed−state inactivation (τ for recovery from closed−state inactivation was
1.2 ± 0.2 s, Fig 4D). Under control conditions, the current amplitude obtained during the second
depolarizing pulse was 16.1 ± 0.9% (n = 7) higher than the current amplitude obtained at the first
depolarizing pulse (Fig 4E, black trace). However, in the presence of 4−AP no significant differ-
ences in current amplitude were observed between the first and second depolarizing pulse and
the difference in current amplitude (%) between the control and 4-AP conditions was found to
be statistically significant (p< 0.001, Fig 4E, red trace). Furthermore, the peak amplitude of both
pulses corresponded to the current amplitude of the second pulse obtained under control condi-
tion. These results indicated that a substantial fraction of the Kv2.1/Kv6.4 channels (~15%)
reached the closed−inactivated state at a holding potential of −80 mV and that 4−AP prevented
(or reduced) this closed state to closed−inactivated state transition due to a faster recovery from
and slower initiation of closed−state inactivation (Fig 4C and 4D). To confirm our hypothesis
further we promoted closed−state inactivation in Kv2.1/Kv6.4 channels by applying our two−
pulse protocol after a 5 s pre−pulse to −60 mV (Fig 4F). This −60 mV pre−pulse induced more
closed−state inactivation under control conditions: the current amplitude of the second depolar-
izing pulse was 56 ± 6% (n = 6) higher than that of the first depolarizing pulse. In presence of
4−AP the difference between the second and first depolarizing test pulse was reduced to only
18 ± 4% (n = 5), as expected if 4−AP reduced the closed−state to closed−inactivated state transi-
tion through an increased recovery rate (at -100 mV) from and slower initiation rate (at -60 mV)
to the closed−inactivated state (Fig 4F). The difference in current amplitudes (%) between control
and 4−AP conditions proved to be statistically significant (p = 0.002).
Interestingly, some other Kv2.1/KvS and homotetrameric Kv2.1 channels display closed−
state inactivation but were inhibited by 4−AP. If the 4-AP induced potentiation and kinetic
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Fig 4. 4−AP affects closed−state inactivation in Kv2.1/Kv6.4 heterotetramers. (A−B) Representative current recordings in control conditions (upper) and
after application of 18 mM 4−AP (bottom) elicited by the pulse protocol shown in the top to investigate the time course of induction (A) and recovery (B) from
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changes in Kv2.1/Kv6.4 channels reflect interference with closed−state inactivation, then 4−AP
should not alter the kinetics of closed−state inactivation of channels that possess a strong pref-
erence for closed−state inactivation but are inhibited by 4−AP. Therefore, we investigated the
effect of 4−AP on the kinetics of closed−state inactivation (induction and recovery) of heterote-
trameric Kv2.1/Kv9.3 (Fig 5) and homotetrameric Kv2.1 (S5 Fig). The same protocols for
induction of (Fig 5A, S5A Fig) and recovery from (Fig 5B, S5B Fig) closed−state inactivation
were used but the voltage of the step to induce inactivation was changed to match the V1/2 of
inactivation of the respective channel (i.e. −45 mV for Kv2.1/Kv9.3 and −20 mV for Kv2.1).
Interestingly, 4−AP had no effect on the kinetics of the closed−state inactivation of Kv2.1/
Kv9.3 (Fig 5C, 5D and 5F) and Kv2.1 (S5C, S5D and S5F Fig) channels although it did reduce
the degree of inactivation (Figs 5C, 5D and 5F, S5C, S5D and S5F). Thus, 4−AP reduced the
degree of inactivation developing at the V1/2 of inactivation–when superimposed on the inhibi-
tion − but was not capable of altering the kinetics of closed−state inactivation in Kv2.1/Kv9.3
and Kv2.1 channels, suggesting that 4−AP interferes with the closed−state inactivation process
of Kv2.1/Kv6.4 channels.
The S6c sequence affects the Kv6.4 specific response to 4−AP
Exchanging the S6c sequence between Kv2.1 and Kv3.1 has been shown to transfer their 4−AP
sensitivity [27]. Similar to Kv6.4, Kv9.3 induces a negative shift in the voltage−dependence of
inactivation but Kv2.1/Kv9.3 currents are blocked by 4−AP (Fig 2). Therefore, the potentiation
of Kv2.1/Kv6.4 currents by 4−AP appears to be a specific feature of the Kv6.4 subunit. To test
whether the S6c sequence of the Kv6.4 subunit confers 4−AP induced potentiation, we replaced
the S6c of Kv6.4 by that of Kv9.3 (chimera Kv6.4_S6c_Kv9.3). This Kv6.4_S6c_Kv9.3 chimera
yielded functional heterotetrameric channels upon co−expression with Kv2.1, and displayed
slightly altered activation kinetics compared to Kv2.1 heterotetrameric channels composed of
either Kv6.4 or Kv9.3 (Fig 6A and 6D). The Kv2.1/Kv6.4_S6c_Kv9.3 channels displayed a volt-
age dependence of activation similar to both Kv2.1 homomeric channels and WT Kv2.1/Kv6.4
or Kv2.1/Kv9.3 heterotetramers (Fig 6E and Table 1). Additionally, the characteristic inactiva-
tion from the closed state was preserved in the chimera and closely resembled that of WT
Kv2.1/Kv6.4 heterotetramers (Fig 6C and 6E). Application of 18 mM 4−AP caused an inhibi-
tion of Kv2.1/Kv6.4_S6c_Kv9.3 currents of 12 ± 3% (n = 7), which is comparable to the
12 ± 1% inhibition of WT Kv2.1/Kv9.3 heterotetramers (p = 0.295) and in marked contrast to
the activator effect in WT Kv2.1/Kv6.4 channels (Fig 6A and 6B). 4−AP did not affect the volt-
age dependence of channel inactivation (p = 0.582). These results showed that exchanging the
S6c region from Kv6.4 to Kv9.3 transferred the 4−AP effect of Kv9.3 to the Kv6.4 subunit
resulting in current inhibition.
The opposite effect might be expected when introducing the S6c sequence of Kv6.4 in Kv9.3
(chimera Kv9.3_S6c_Kv6.4). This Kv9.3_S6c_Kv6.4 chimera also yielded functional heterote-
trameric channels upon co−expression with Kv2.1 (S6A Fig) but displayed a significantly
closed−state inactivation. The dotted lines represent the exponential fit to determine the closed−state inactivation initiation (A) and recovery (B) rate. (C−D)
Induction at −60 mV (C) and recovery at −100 mV (D) of closed−state inactivation obtained by plotting the normalized P2/P1 amplitude in function of time.
Solid lines represent the exponential fit. Note that 18 mM 4−AP decreased the amount of inactivation and slowed the initiation rate of closed−state
inactivation (C) while accelerating the recovery from closed−state inactivation (D). (E) The twin pulse protocol (top) reveals that under control conditions
(black trace) a fraction of channels can be recovered from their closed−inactivated state by a 10s pulse to −100mV, seen as an increase in peak amplitude
from P1 to P2. With 4−AP (red trace), the amplitude at both test pulses were the same as P2 in control, suggesting that 4−AP interferes with the transition
from the closed to the closed−inactivated state. The holding potential was kept at −80 mV between different current traces. (F) Inducing more closed−state
inactivation by a 5s prepulse to −60 mV increased the difference in peak amplitude between P1 and P2 pulse by approximately 50% in control. 4−AP reduced
the current less after the prepulse to −60 mV compared to control conditions and reduced the difference in peak amplitude of the test pulse to approximately
15%, suggesting that 4−AP interfered with the closed to closed−inactivated state transition.
doi:10.1371/journal.pone.0141349.g004
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Fig 5. 4−AP does not affect closed−state inactivation in Kv2.1/Kv9.3 heterotetramers. (A−B) Representative current recordings under control (upper)
and 4−AP (bottom) conditions elicited by the pulse protocols shown on top. The pulse protocols were used to investigate the induction (A) and recovery (B) of
closed−state inactivation. The dotted lines represent the exponential fit to determine these rate constants. (C−D) The normalized plot of induction at −45 mV
(C) and recovery at −100 mV (D) of closed−state inactivation was obtained as described in Fig 4. Solid lines represent the exponential fit. 4−AP decreased
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altered voltage dependence of activation (p< 0.001) and inactivation (p = 0.002), compared to
wilt−type Kv2.1/Kv9.3 heterotetramers. Furthermore, the gating of Kv2.1/Kv9.3_S6c_Kv6.4
channels significantly differed from the voltage−dependence of activation (p = 0.002) and inac-
tivation (p = 0.001) of homotetrameric Kv2.1 channels. The Kv2.1/Kv9.3_S6c_Kv6.4 channels
displayed a voltage dependence of activation and inactivation that was shifted by approxi-
mately 10 and 20 mV towards depolarized potentials, respectively (S6E Fig and Table 1). Due
the total amount of inactivation developing at the V1/2 of inactivation but did not significantly alter the induction and recovery rate of closed−state inactivation.
(E) The twin pulse protocol (top), as described in Fig 4, revealed that under control conditions (black trace) no substantial fraction of Kv2.1/Kv9.3 channels is
in a closed−inactivated state as the peak amplitude between P1 and P2 is equal. 4−AP inhibited both P1 and P2 to the same extent. Thus, in contrast to
Kv2.1/Kv6.4 channels, no closed−inactivated Kv2.1/Kv9.3 channels can be recovered by 4−AP or the −100 mV recovering pulse. (F) Bar chart of the kinetics
of closed−state inactivation before and after application of 4−AP: recovery rate (left), induction rate (middle) and degree of inactivation after a 10s pulse to
−45 mV (right). * represent statistical significance. Black and grey bars represent control and 18 mM 4−AP, respectively.
doi:10.1371/journal.pone.0141349.g005
Fig 6. Involvement of the S6c domain in the KvS specific response to 4−AP. (A) Typical current traces for the Kv2.1/Kv6.4_S6c_Kv9.3 chimera without
(left) and with 4−AP (right) revealing inhibition by 4−AP, comparable to its effect on Kv2.1/Kv9.3_WT currents. The pulse protocol is shown above the current
traces. (B) 4−AP (red trace) causes a small inhibiting effect of Kv2.1/Kv6.4_S6c_Kv9.3 currents which is the opposite of the 4−AP effect on the Kv2.1/
Kv6.4_WT currents. Control trace shown in black. (C) The twin pulse protocol from Fig 4E was repeated on the Kv6.4_S6c_Kv9.3 chimera to illustrate that: 1)
closed−state inactivation is still present at −80mV, 2) inactivated channels can be recovered in a 10s pulse to −100 mV and 3) 4−AP is unable to interfere with
the closed−state inactivation of the Kv6.4_S6c_Kv9.3 chimera. (D) Activation and deactivation kinetics of the Kv2.1/Kv6.4_S6c_Kv9.3 heterotetramers
(black circles). Time constants of the chimera were obtained with a single exponential function which resulted in a single fast component that remained
unaltered under the influence of 4−AP (red circles). This chimera lacked the pronounced slow component present in Kv2.1/Kv6.4_WT heterotetramers (Fig
3C). (E) Voltage−dependence of activation (open symbols) and inactivation (closed symbols) of the Kv2.1/Kv6.4_S6c_Kv9.3 chimera obtained like for the
WT Kv2.1/Kv6.4 heterotetramers in Fig 3. Both were nearly the same as for WT Kv2.1/Kv6.4 currents and remained unaffected by 4−AP application (red
symbols).
doi:10.1371/journal.pone.0141349.g006
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to the shifted voltage dependency of inactivation and the reduction of the U−shaped inactiva-
tion profile, it appears that the characteristic closed−state inactivation was lost in Kv2.1/
Kv9.3_S6c_Kv6.4 heterotetramers. Therefore, 4−AP might have no potentiating effect on
Kv2.1/Kv9.3_S6c_Kv6.4 channels as 4−AP affects the closed to closed−inactivated state transi-
tion. Indeed, no difference in current amplitude can be observed between the 1st and 2nd depo-
larizing pulse to + 60 mV under control conditions (S6C Fig). Furthermore, 4−AP inhibited
both pulses of the twin pulse protocol but the ratio between the 1st and 2nd depolarizing pulse
remained the same. The combined results of the Kv6.4_S6c_Kv9.3 and Kv9.3_S6c_Kv6.4 chi-
mera’s illustrate that potentiation of Kv6.4 currents may involve the presence of the Kv6.4’s
S6c sequence and a strong closed−state inactivation process.
Discussion
4−AP potentiates currents mediated by Kv2.1/Kv6.4 heteromeric
channels
The S6c domain has been shown to form a binding site for channel inhibitors such as 4−AP,
flecainide, propafenone and quinidine [9–12,35]. The S6c of most Kv channels contains a con-
served PXP motif that, besides being important for channel gating [6,36], has been shown to
modulate the channel´s sensitivity to 4−AP and internal pore blockers (e.g. quinidine). Substi-
tuting the second proline of the PXP motif by an alanine drastically decreased the affinity for 4
−AP in Shaker [25]. Interestingly, all the members of the Kv7 (KCNQ) subfamily lack a full
PXP motif (Fig 1) and neither of them is sensitive to 4−AP [37]. The fact that the KvS subunits
also miss the 2nd proline of the PXP motif (Fig 1) raised the question whether heteromeric
Kv2.1/KvS channels display a different pharmacological profile for 4−AP compared to homo-
meric Kv2.1 channels.
To address this question we tested 4−AP on the different KvS subfamilies using Kv5.1,
Kv6.4, Kv8.1 and Kv9.3 as representative members. Our data show that Kv5.1, Kv8.1 and
Kv9.3 heteromeric Kv2.1 channels displayed a reduced affinity for 4−AP compared to Kv2.1
homotetramers (Fig 2C), which is in agreement with previous findings on Kv9.3 channels [16].
However, the most intriguing change in 4−AP sensitivity was induced by the Kv6.4 subunit: in
this case 4−AP potentiated, rather than inhibited, Kv6.4 currents. Interestingly, in mouse blad-
der smooth muscle cells and gastrointestinal smooth muscle cells it has been demonstrated
that 4-AP was capable of potentiating native Kv currents [38,39]. In addition, the expression of
several KvS subunits was confirmed in mouse bladder smooth muscle cells [38,40]. Impor-
tantly, Thorneloe and Nelson documented both the presence of Kv6.4 (in their study named
Kv6.3 following the old nomenclature) in isolated bladder myocytes, and potentiation of the
delayed rectifier Kv current by 10 mM 4-AP in these cells, thus providing physiological rele-
vance for our heterologously obtained data [38].
The potentiation was a unique characteristic of 4−AP since the internal pore blockers quini-
dine and flecainide still blocked Kv2.1/Kv6.4 channels, although with a slightly higher affinity
compared to homotetrameric Kv2.1 channels (S2C Fig). A similar increase in quinidine affinity
was also observed in the Shakermutant with a PXA sequence [25]. The potential to convert the
4−AP effect from inhibition to current potentiation appears not to be conserved within all
members of the Kv6 family since a previous study reported that Kv2.1/Kv6.2 heterotetramers
display a higher degree of current inhibition by 18 mM 4−AP compared to Kv2.1 homotetra-
mers [41]. We observed that Kv2.1/Kv6.3 heterotetramers are also inhibited by 4-AP (S1 Fig)
strengthening the fact that the 4-AP induced current potentiation is not conserved in the Kv6
subfamily. Note that Kv2.1/Kv6.3 channels do not display a major hyperpolarizing shift of the
inactivation curve, as previously reported by Ottschytsch et al. (then designated as Kv10.1)[15].
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Thus, each Kv2.1/KvS heterotetramer may harbor a unique affinity for 4−AP different from
Kv2.1 homotetramers.
4−AP interferes with closed−state inactivation transition
In heterotetrameric Kv2.1/Kv6.4 channels, the voltage dependence of inactivation is shifted by
40 mV towards more negative potentials without substantially affecting the voltage dependence
of activation. Consequently, the Kv2.1/Kv6.4 channels start to inactivate at potentials that are
below the apparent threshold for channel activation. Typically, ion channels with preferential
closed−state inactivation possess a U− (or J) shaped (steady state) inactivation profile, i.e. at
stronger depolarizations the degree of inactivation diminishes, a characteristic strongly present
in Kv2.1/Kv6.4 channels [32,42–44]. At −80 mV, approximately 12% of the Kv2.1/Kv6.4 chan-
nels populate the closed−inactivated state under control conditions, as evidenced using a twin
pulse protocol in Fig 4E, and 4−AP restored this difference in current amplitude suggesting a
possible interference with closed−state inactivation. An extra 5 s prepulse to −60 mV in the
twin pulse protocol increased the total amount of closed−state inactivation and allowed 4−AP
to recover more Kv2.1/Kv6.4 channels from their inactivated state, strengthening this hypothe-
sis (Fig 4F). If Kv2.1/Kv6.4 channels exhibit a small, non zero open probability (Po) at −60 mV,
it cannot be excluded that, in combination with the duration of the conditioning pulse, 4−AP
(partly) acts on open−state inactivation, which has been previously reported for the Shaker
channel [45]. However, the observations that 4−AP reduced and slowed induction of inactiva-
tion, enhanced the rate of recovery and diminished the degree of U−shaped inactivation all
points towards a loss of closed−state inactivation and more inactivation at positive potentials
(e.g. +80 mV). The latter observation can be explained by a strengthening of open−state inacti-
vation, as suggested by the macroscopic current kinetics in Fig 3A, which is in contrast to pre-
vious findings that 4−AP can reduce open−state inactivation [45]. The apparent increase in
open−state inactivation could be a consequence of open−channel block however this is rather
unlikely due to the potentiation of the peak current amplitude. In summary, 4−AP most likely
interferes with closed−state inactivation (Figs 3D and 4A–4D) and the ‘loss’ of closed−state
inactivation allows the Kv2.1/Kv6.4 channels to inactivate from their open−state. Hence, the
current potentiation observed for Kv2.1/Kv6.4 channels is the result of a reduction of the
amount of Kv2.1/Kv6.4 channels present in a closed−inactivated state at the holding potential
of −80 mV.
The exact underlying mechanism of closed−state inactivation has not been resolved yet, but
several studies indicate that it involves a dynamic coupling between S6c and the S4−S5 linker,
which forms the electromechanical coupling that translates VSD movement into BC gate open-
ing [43,46]. If an uncoupling occurs at this S6c/S4−S5linker interface, BC gate (and channel)
opening is prevented and the channel enters a nonconductive, inactivated state. Due to the sub-
unit−cooperative nature of BC gate opening in Shaker−related Kv channels, disrupting the
electromechanical coupling of one subunit (e.g. Kv6.4) would be sufficient to enter this non-
conductive state. A similar mechanism of uncoupling has been proposed for hyperpolarized
cyclic nucleotide−gated (HCN) channels where the uncoupling between the VSD and the
channel gate (at hyperpolarized potentials) results in desensitization to voltage, observed as
gating charge immobilization [47,48]. Interestingly, such a desensitization to voltage, observed
as gating charge immobilization, also occurs in Kv4.2 channels that exhibit prominent closed
−state inactivation [49].
If closed−state inactivation involves a collapse of the selectivity filter, as in C−type inactiva-
tion, then the process is most likely triggered by rearrangements in S6c (in the vicinity of the
BC gate). Indeed, in C−type inactivation the S6c reorientations associated with BC gate
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opening are transmitted upwards along the S6 helix up to the level of the selectivity filter [50–
52]. The final collapse of the selectivity filter is probably a process whereby the destabilizing
input of 1 subunit is sufficient to trigger inactivation [53,54]. If closed−state inactivation has a
similar mechanism, the rearrangements in S6c should occur, and be transmitted upwards,
before channel opening. For the Kv2.1/Kv6.4 heteromeric channels we showed that the gating
charge movement displays a component at hyperpolarized potentials with a voltage depen-
dence that matches the voltage−dependence of inactivation [55]. This suggests that at −80 mV
already a substantial amount of the gating charge moves (originating from the S4 movement of
either the Kv6.4 or Kv2.1 subunits) which could potentially be translated in conformational
changes of S6c associated with inactivation gating. It is currently not known whether the S6c of
Kv6.4 actually moves, but if it does and if this movement occurs at more hyperpolarized poten-
tials, channel inactivation could be triggered. In this model our data would strengthen the
hypothesis that one subunit is sufficient to initiate the collapse of the selectivity−filter [50,51].
Here we propose that 4−AP modulates closed−state inactivation in the heteromeric Kv2.1/
Kv6.4 channels either by stabilizing the coupling at the S6c/S4−S5linker interface or by pre-
venting S6c reorientations associated with inactivation gating. In tuberomammillary neurons,
it has been demonstrated that 4−AP enhanced the Kv4 A−type current (IA) at subtreshold
potentials [56]. It was suggested that 4−AP−bound channels were unable to inactivate resulting
in a potentiation at subthreshold potentials. This observation fits with our finding that 4−AP
prevents closed−sate inactivation, a process that is also present in Kv4.2 channels [31].
Molecular determinants of the 4−AP binding site
Location of the 4−AP binding site remains uncertain but both the S4−S5 linker and the cyto-
plasmic half of S5 and S6 have been shown to be important for 4−AP sensitivity in Kv channels
[10,27,30,57]. Molecular docking studies of aminopyridines confirmed this and placed the 4
−AP binding pocket at the S4−S5 linker and S6c interface [58]. However, the location of 4−AP
binding site does not allow us to rule out whether closed−state inactivation arises from uncou-
pling the S6c/S4−S5linker interface or conformational changes that lead to selectivity filter col-
lapse. In both cases, 4−AP unbinding is required in order for closed−state inactivation to
occur.
Kv2.1/Kv9.3 heteromers display a large hyperpolarizing shift in the voltage−dependence of
inactivation (similar to Kv2.1/Kv6.4 heteromers), but they are inhibited, rather than potenti-
ated by 4−AP. This suggests that the hyperpolarized position of the inactivation curve is not
the only determinant for the potentiating effect of 4−AP. Kirsch and Drewe were able to trans-
fer the high affinity of Kv3.1 for 4−AP onto Kv2.1 by exchanging both the S5 and S6 domains
[27]. Given the sequence differences in S6c between Kv6.4 and Kv9.3 we exchanged this region
and found that substituting S6c in Kv6.4 by the Kv9.3 sequence (Kv2.1/Kv6.4_S6c_Kv9.3)
transferred Kv9.3´s 4−AP effect onto Kv6.4 subunits, i.e. the Kv2.1/Kv6.4_S6c_Kv9.3 channels
were inhibited by 4−AP instead of potentiated (Fig 6). However, the opposite substitution, i.e.
replacing the S6c region of Kv9.3 by the Kv6.4 sequence, did not transfer the 4−AP potentiation
effect onto the Kv9.3 currents. Interestingly, the Kv2.1/Kv9.3_S6c_Kv6.4 channels displayed
altered biophysical properties, including a depolarizing shift of approximately 20mV in the
voltage dependence of inactivation and a reduced degree of U−shaped inactivation. This sug-
gests that the 4−AP effect on Kv2.1/KvS heterotetramers is dependent on both the S6c
sequence and the presence or absence of the prominent closed−state inactivation process. It
cannot be excluded that other channel regions are involved in creating the 4−AP binding site,
especially the S4−S5 linker and the cytoplasmic half of S5 due to their contribution to dynamic
coupling in the known mechanism of closed−state inactivation.
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General conclusion
Our present study reports that KvS subunits have the ability to alter the pharmacological pro-
file of Kv2.1 channels upon heterotetramerization. Thus, heterotetrameric Kv2/KvS channels
not only display unique biophysical properties but also unique pharmacological effects as is the
case for 4−AP on Kv2.1/Kv6.4 channels where it interferes with the closed−state inactivation
process. It has been demonstrated that heterotetrameric Kv2.1/KvS channels regulate several
(patho)physiological processes, e.g. mutations of Kv8.2 contribute to epilepsy susceptibility, as
they contribute to several native delayed rectifier currents [19,20,59,60]. Because of their struc-
tural differences and unique biophysical properties, different KvS subunits can not only alter
the Kv2 pharmacology, but it is also likely that KvS subunits could be pharmacologically specif-
ically targeted, without influencing Kv2 homomers, allowing interventions in physiological
processes regulated by unique Kv2/KvS heteromers.
Supporting Information
S1 Fig. 4-AP inhibits heterotetrameric Kv2.1/Kv6.3 channels. (A) Representative current
recordings of Kv2.1/Kv6.3 before (left) and after application of 4-AP (right). 4-AP inhibited
Kv2.1/Kv6.3 currents and modified the activation kinetics. Voltage protocol is shown on top.
(B) Voltage dependence of activation with (red) and without 4-AP (black). 4-AP slightly
shifted the activation curve towards depolarized potentials. (C) Concentration-dependence of
the 4-AP inhibition. The blocking potency of 4-AP on Kv2.1/Kv6.3 is decreased in comparison
to homotetrameric Kv2.1 channels (dotted line). The solid line represent a fit with the Hill
equation with an IC50 of 15.5 ± 2.9 mM (n = 5). (D) Activation and deactivation kinetics of the
Kv2.1/Kv6.3 heterotetramers. Time constants were fitted with a double exponential function
and yielded a fast (circles) and slow (triangles) component. 4-AP (red) slowed both the fast
and slow component of activation while the deactivation components remained unaffected. (E)
The voltage dependence of inactivation before (black) and after 4-AP application (red). Kv6.3
does not affect the inactivation properties significantly as the inactivation curve overlaps
completely with that of homotetrameric Kv2.1 channels (dotted line). 4-AP shifted the inacti-
vation curve towards depolarized potentials and the extent of the shift was comparable to the
shift of the activation curve.
(TIF)
S2 Fig. Kv2.1/Kv6.4 channels remain sensitive to the channel blockers quinidine and flecai-
nide. (A) Representative current recording before (black trace) and after 3 μM quinidine (red
traces) of Kv2.1 (left) and Kv2.1/Kv6.4 channels (right). (B) Concentration dependence for
inhibition by quinidine of Kv2.1 (filled circles) and Kv2.1/Kv6.4 (open circles) channels. Con-
centration−effect curves were obtained by plotting the normalized amount of block in function
of the applied concentration and fitted with the Hill equation as described in the material and
method section. Note the leftward shift of the Kv2.1/Kv6.4 concentration−effect curve com-
pared to that of Kv2.1 homotetramers which corresponds to a twofold difference in IC50 value.
(C) Effect of flecainide on Kv2.1 (left) and Kv2.1/Kv6.4 (right) channels. (D) Concentration
−effect curves for flecainide inhibition of Kv2.1 (filled circles) and Kv2.1/Kv6.4 (open circles)
channels obtained like the quinidine concentration−effect curve in panel B. As for quinidine,
the heteromeric Kv2.1/Kv6.4 channels are more sensitive to flecainide.
(TIF)
S3 Fig. Effects of 4−AP on homotetrameric Kv2.1 channels. (A) Typical Kv2.1 current traces
without (left) and with (right) 18 mM 4−AP revealing strong current inhibition and changes in
activation kinetics. The pulse protocol is shown above the current traces. (B) Voltage
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dependence of activation for Kv2.1 obtained like for the WT Kv2.1/Kv6.4 heterotetramers in
Fig 3. (C) Activation and deactivation kinetics of Kv2.1. Time constants were obtained with a
single exponential function as previously described for the Kv2.1/Kv6.4_S6c_Kv9.3 chimera in
Fig 6. Kv2.1 kinetics are shown as black circles and as red circles when 4−AP is present.
(TIF)
S4 Fig. Time dependent analysis of the inactivation properties of Kv2.1/Kv6.4. (A) Voltage
dependence of inactivation, recorded as a function of time. Five inactivation protocols were
recorded over a time span of 25 minutes and evaluated for a potential drift of the V1/2 of inacti-
vation. A slight hyperpolarizing drift of the inactivation curve can be observed. (B) Compari-
son of the voltage dependence of inactivation before and after 4−AP application. After
recording 5 repetitive inactivation protocols, 4−AP still shifted the inactivation curve towards
depolarized potentials. (C) Bar chart showing the mean V1/2 of inactivation and S.E.M. at the
different time intervals. 4-AP still shifted the V1/2 of inactivation significantly ( represent sta-
tistical significance) towards depolarized potentials. Colored dots/bars represent inactivation
recorded, after obtaining a ‘whole cell’ patch configuration, at: 5 (black), 10 (red), 15 (blue), 20
(green) and 25 (orange) minutes. 4-AP data is shown in grey.
(TIF)
S5 Fig. Closed−state inactivation kinetics of Kv2.1 homotetramers are not modulated by 4
−AP. (A and B) Representative current recordings in control conditions (upper) and after
application of 18 mM 4−AP (bottom) elicited by the pulse protocol shown on top to investigate
the time course of induction (A) and recovery (B) from closed−state inactivation. The dotted
lines represent the exponential fit to determine the closed−state inactivation induction (A) and
recovery (B) rate. (C and D) Induction at −20 mV (C) and recovery at −100 mV (D) of closed
−state inactivation where determined as described in Fig 4. Solid lines represent the exponen-
tial fit. 4-AP did not alter the induction or recovery rate of closed−state inactivation. However,
18 mM 4−AP significantly reduced the degree of inactivation that developed during the proto-
cols. (E) Twin pulse protocol (top), as used in Fig 4, revealed that under control (black trace)
and 4−AP (red trace) conditions no fraction of channels can be recovered from their closed
−inactivated state by a 10 s pulse to −100 mV. Thus, at the holding potential of −80 mV, no
substantial amount of closed−state inactivation develops for homotetrameric Kv2.1 channels.
(F) Bar chart of the kinetics of closed−state inactivation before and after application of 4−AP:
induction rate (left), recovery rate (middle) and degree of inactivation after a 20 s pulse to −20
mV (right).  represent statistical significance). Black and grey bars represent control and 18
mM 4−AP, respectively.
(TIF)
S6 Fig. Kv2.1/Kv9.3_S6c_Kv6.4 heterotetramers are inhibited by 4−AP. (A) Typical current
traces for the Kv2.1/Kv9.3_S6c_Kv6.4 chimera without (left) and with 4−AP (right). The pulse
protocol is shown on top. (B) 4−AP (red trace) slightly inhibited Kv2.1/Kv9.3_S6c_Kv6.4 cur-
rents (17 ± 3%, n = 6) comparable to the 12 ± 1% inhibition of WT Kv2.1/Kv9.3 currents seen
in Fig 2. Control trace shown in black. (C) The twin pulse protocol from Fig 4E illustrates that
the prominent closed−state inactivation was no longer present in Kv2.1/Kv9.3_S6c_Kv6.4 het-
erotetramers, seen as equal peak amplitudes at the two test pulses P1 and P2. 4−AP inhibited
peak current amplitudes at P1 and P2 to a similar extent. (D) Activation and deactivation
kinetics of the Kv2.1/Kv9.3_S6c_Kv6.4 heterotetramers (black circles). Time constants of acti-
vation were obtained with a single exponential function. Similar to the Kv2.1/Kv6.4_S6c_Kv9.3
chimera in Fig 6, the Kv2.1/Kv9.3_S6c_Kv6.4 chimera lacked a pronounced slow component
present in Kv2/Kv6.4 heterotetramers (Fig 3C). (E) Voltage dependence of activation (open
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symbols) and inactivation (closed symbols) of the Kv2.1/Kv9.3_S6c_Kv6.4 chimera. Both were
shifted towards depolarized potentials compared to the WT Kv2.1/Kv9.3 inactivation (dashed
line), resulting in a loss of the pronounced closed−state inactivation process. 4−AP (red sym-
bols) had no significant effect on the gating parameters. For comparison, homomeric Kv2.1
(dotted line) before 4−AP application is included.
(TIF)
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